Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-04 · accession 0001773751-23-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-06 | 2023-04-04 | HIMS | Becklund Irene | PAO | M - OptEx | $1.75 | +567 | 567 | New | +$992.25 |
| DM | 2023-04-06 | 2023-04-04 | HIMS | Becklund Irene | PAO | S - Sale+OE | $10.30 | -15.9K | 0 | -100% | -$163.7K |
| D | 2023-04-06 | 2023-04-04 | HIMS | Becklund Irene | PAO | M - OptEx | $0.00 | -567 | 16.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-04 | M | A | 567 | $1.75 | 567 | D | — | — | (F2) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2023-04-04 | S | D | 15,323 | $10.30 | 0 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022 by the Reporting Person. |
| 3 | Common | Class A Common Stock | 2023-04-04 | S | D | 567 | $10.30 | 0 | D | — | — | (F2) The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2022 by the Reporting Person. |
| 4 | Derivative | Stock Option (right to buy) | 2023-04-04 | M | D | 567 | $0.00 | 16,420 | D | $1.75 · — to 2029-07-08 | 567 Class A Common Stock | (F3) 25% of the shares of Class A common stock subject to the Stock Option vested on June 3, 2021 and the remaining 75% vest in a series of thirty-six successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the issuer. |